The Hormone Replacement Therapy Market was valued at 19.9 billion in 2022 and it is anticipated to grow up to USD 36.4 billion by 2032, at a CAGR of 6.2% during the forecast period.
hormone replacement therapy (HRT) is a treatment technique for replacing and/or replenishing hormones in the human body, which are at inadequate levels than those required for the normal physiology of the human body. The most prominent application of HRT is in the treatment of symptom alleviation of menopause.
View The Full Report Here –https://www.globalinsightservices.com/reports/hormone-replacement-therapy-market/?utm_id=Pranalip
Market Trends and Drivers
One significant growth driver for the Hormone Replacement Therapy (HRT) market is the increasing awareness and acceptance of hormone replacement therapies for managing symptoms associated with menopause. As more women become educated about the benefits of HRT in alleviating hot flashes, night sweats, vaginal dryness, and other menopausal symptoms, the demand for these therapies is expected to rise. Moreover, with advancements in medical research and technology, the development of innovative and more targeted hormone therapies has become possible, catering to individual patient needs and preferences. This expanding range of treatment options, coupled with a growing aging population worldwide, is anticipated to fuel the growth of the HRT market in the coming years.
Market Restraints and Challenges
One of the key restraints in the Hormone Replacement Therapy (HRT) market is the potential risk associated with long-term use of hormone replacement products. While HRT can provide relief from menopausal symptoms and other hormonal imbalances, studies have suggested an increased risk of certain health conditions, such as cardiovascular diseases and certain types of cancer, with prolonged use of HRT. These safety concerns have led to cautious prescribing practices and decreased patient acceptance, limiting the growth potential of the HRT market. Additionally, the availability of alternative therapies and the preference for non-hormonal treatment options further restraining the market growth.
The report analyses the global Hormone Replacement Therapy Market based on Therapy Type, Route of Administration, Indication, and Region.
Hormone Replacement Therapy Market by Therapy Type
Based on Therapy Type, it is analyzed across Estrogen Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, and Progestogen Hormone Replacement Therapy. The estrogen and progesterone replacement therapy segment emerged as the dominant market leader in the peptide synthesis industry. This significant market share can be attributed to the rising demand for hormone replacement therapies among individuals experiencing hormonal imbalances or undergoing menopause. According to the American Congress of Obstetricians and Gynecologists, around 6,000 women reach menopause daily in the U.S. Estrogen and progesterone replacement therapies are widely used to alleviate symptoms and promote overall well-being, thereby driving the growth of this particular segment in the peptide synthesis market.
Moreover, advancements in peptide synthesis technologies and the availability of innovative delivery systems have further propelled the adoption of estrogen and progesterone replacement therapy. As the aging population continues to expand globally and individuals seek ways to manage hormonal imbalances and associated symptoms, the estrogen and progesterone replacement therapy segment is expected to maintain its strong market position. The peptide synthesis market will continue to witness significant growth, driven by the increasing demand for hormone replacement products and ongoing research to develop novel peptides that offer enhanced efficacy and improved patient outcomes.
Request A Sample Of This Report –https://www.globalinsightservices.com/request-sample/GIS21882/?utm_id=Pranalip
Hormone Replacement Therapy Market by Route of Administration
Based on route of administration, it is categorized into parenteral, oral, and transdermal. During the projected period, the parenteral segment is anticipated to experience significant growth. This growth can be attributed to advancements in drug delivery methods, particularly through pen-based drug delivery systems. These systems are expected to enhance patient compliance and simplify administration, thus driving the expansion of this segment. Some popular pen-based products include the Genotropin Mixer Pen, Norditropin FlexPro Pen, and Humatrope HumatroPen.
Additionally, the introduction of a new long-acting growth hormone injection is predicted to further fuel the growth of this segment. For example, in January 2022, Pfizer, Inc. and OPKO Health, Inc. obtained approval from the Ministry of Health, Labour and Welfare in Japan to market NGENLA, a next-generation long-acting growth hormone injection for treating growth hormone disorders. This product offers the advantage of a once-a-week dosage regimen, contributing to its potential impact on segment growth.
Hormone Replacement Therapy Market by Indication
On the basis of Indication, it is segmented into Hypothyroidism, Menopause, Male Hypogonadism, Growth Hormone Deficiency, and Others. In 2022, the hypoparathyroidism segment is anticipated to experience substantial growth in the forecast period, driven by the development of novel treatments and the introduction of new products. For instance, in September 2020, Ascendis Pharma A/S presented its TransCon technologies at the American Society for Bone and Mineral Research (ASBMR) 2020 Annual Meeting. The company also disclosed the top-line results of the phase 2 clinical trial for TransCon PTH at the same event. Currently, the drug is undergoing phase 3 clinical trials. Upon approval and subsequent launch, this product will offer additional options for parathyroid hormone replacement therapy
On the other hand, menopause segment emerged as the dominant force in the market, capturing a share. This can be attributed to the rising number of women experiencing menopause. According to the UN’s 2020 global estimates, there were 958 million women aged 50 and above, and this number is projected to reach 1.65 billion by 2050. As a result, a significant population of women is expected to spend a considerable portion of their lives after menopause in the future. However, the age of menopause can vary due to various factors, including natural factors such as habitat and genetics, which influence the timing of menopause for individuals.
Regional Analysis of Hormone Replacement Therapy Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America is projected to maintain its dominant position in the Hormone Replacement Therapy market throughout the forecast period. This region is expected to experience substantial growth throughout the forecast period. The significant market share can be attributed to several factors, including major product launches, collaborative agreements among manufacturers, and favorable reimbursement policies. An example of such a success is the approval of Sogroya (somapacitan-beco), a hormone replacement therapy product developed by Novo Nordisk A/S, by the U.S. FDA in August 2020. This particular product is administered once weekly via the subcutaneous route and is targeted towards adults diagnosed with growth hormone deficiency. The region’s strong healthcare infrastructure, increasing geriatric population, rising prevalence of hormonal disorders, and extensive research and development activities contribute to its leadership position. Additionally, favorable reimbursement policies, high healthcare expenditure, and robust pharmaceutical industry further propel the growth of the HRT market in North America, attracting both domestic and international players to invest in this lucrative market segment.
Customise This Report As Per Your Requirements –https://www.globalinsightservices.com/request-customization/GIS21882/?utm_id=Pranalip
Major Players in the Hormone Replacement Therapy Market
Market players are focusing on strategic collaborations to enhance their product offerings. Some prominent participants in the global Hormone Replacement Therapy market include AbbVie (U.S.), Allergan plc (U.S.), Amgen (U.S.), Bayer AG (Germany), Belmar Pharma Solutions (U.S.), Endo International plc (Ireland), Merck KGaA (Germany), Mithra Pharmaceuticals (Belgium), Novo Nordisk A/S (Denmark), and Pfizer Inc. (U.S.). among others.
COVID-19 Impact
The Hormone Replacement Therapy market has witnessed a significant impact due to the emergence of COVID-19, as peptides are increasingly being developed and repurposed in the search for therapeutics to treat the virus. According to an update from ClinicalTrials.gov in August 2022, over 100 peptide drugs are currently under development for treating COVID-19, including 15 synthetic peptides specifically targeting acute respiratory distress syndrome (ARDS) and other respiratory illnesses caused by SARS-CoV-2 infection. A 2022 article titled “Peptide-Based Vaccines and Therapeutics for COVID-19” highlighted the usefulness of peptides in addressing the urgent need for alternative COVID-19 therapies. Peptides offer advantages such as target selectivity, improved interactions, and reduced toxicity. Furthermore, minor structural modifications can enhance their metabolism, allowing for prolonged and long-acting effects. Consequently, the Hormone Replacement Therapy market has experienced a significant impact due to the influence of COVID-19.
Buy Now-https://www.globalinsightservices.com/checkout/single_user/GIS21882/?utm_id=Pranalip
Research Scope
- Scope – Highlights, Trends, Insights. Attractiveness, Forecast
- Market Sizing – Product Type, End User, Offering Type, Technology, Region, Country, Others
- Market Dynamics – Market Segmentation, Demand and Supply, Bargaining Power of Buyers and Sellers, Drivers, Restraints, Opportunities, Threat Analysis, Impact Analysis, Porters 5 Forces, Ansoff Analysis, Supply Chain
- Business Framework – Case Studies, Regulatory Landscape, Pricing, Policies and Regulations, New Product Launches. M&As, Recent Developments
- Competitive Landscape – Market Share Analysis, Market Leaders, Emerging Players, Vendor Benchmarking, Developmental Strategy Benchmarking, PESTLE Analysis, Value Chain Analysis
- Company Profiles – Overview, Business Segments, Business Performance, Product Offering, Key Developmental Strategies, SWOT Analysis.
With Global Insight Services, you receive:
10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Infographic excel data pack, easy to analyze big data
- Robust and transparent research methodology
- Unmatched data quality and after sales service
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.